Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
117
NCT05116215
To Evaluate the Safety of Treating Autoimmune Diseases With Molecular Hydrogen Supplement
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 13, 2021
Completion: Aug 12, 2022
NCT05196295
To Evaluate the Safety of Treating Rheumatologic and Metabolic Patients With Molecular Hydrogen Supplement.
Start: Jan 11, 2022
Completion: Jul 30, 2022
NCT06401785
To Evaluate the Efficacy of Oral Molecular Hydrogen Supplement in Patients With Chronic Diseases
Phase: Phase 2
Start: May 11, 2024
Completion: Jan 29, 2025